GUARDION HEALTH SCIENCES, INC. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2022-05-25: Study NCT05763940; Company role Collaborator; Phase Not applicable; Status Unknown.
- 2021-05: Study NCT04676126; Company role Collaborator; Phase Phase 4; Status Withdrawn.
- 2018-01-19: Study NCT03946085; Company role Lead sponsor; Phase Not applicable; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2022-05-25 | NCT05763940 Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals | Collaborator Lead: Western University of Health Sciences | Not applicable | Unknown | Dry Eye Syndromes; Age-Related Macular Degeneration; Omega 3 Index | 130 | 2024-06-25 |
| 2021-05 | NCT04676126 Augmented Macular Pigment-containing Nutraceutical and Central Visual Function | Collaborator Lead: University of the Incarnate Word | Phase 4 | Withdrawn | Glaucoma; Glaucoma Eye; Glaucoma, Open-Angle | 0 | 2022-05 |
| 2018-01-19 | NCT03946085 Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD) | Lead sponsor | Not applicable | Completed | Retinal Drusen; Age-related Macular Degeneration; Macular Degeneration | 79 | 2018-11-01 |